OpenAI is offering eligible life-sciences labs at U.S. universities up to 30 free ChatGPT Business Standard seats for a year, but access to its specialized GPT-Rosalind model still requires separate approval. The new Rosalind Academic Plan is an access program, not a new model release, and it does not include API use.
GPT-Rosalind is OpenAI’s model for life-sciences research. Its Rosalind Workbench coordinates tools for tasks such as medicinal chemistry and genomics. OpenAI introduced the model in April; the October 15 announcement adds a subsidized route for academic labs to use it alongside the company’s other frontier models.
Free seats do not guarantee model access
Eligible labs can receive up to 30 named Business Standard seats at no charge for up to 12 months. The plan also includes commercially available OpenAI frontier models, subject to usage limits. A lab must still receive approval before members can use GPT-Rosalind.
The offer is currently limited to academic labs at U.S. universities. A principal investigator or lab lead applies for a lab without an OpenAI Enterprise agreement. Researchers at universities that already have such an agreement must request access through the university’s existing process. OpenAI says it verifies the institution and the lead, reviews the lab’s research and intended use, and designates a safety contact before activation. The company says safeguards continue through monitoring after access is granted.
The plan does not provide API access or credits. OpenAI says research data shared through the plan is not used to train its models by default. Its help guidance also says the academic offer based on ChatGPT Business is separate from Enterprise privacy arrangements, so institutions should check which data-handling controls apply before adding research material.
OpenAI shares intended uses, not a comparative study
OpenAI describes labs using GPT-Rosalind for work including protein design and neurodegeneration research. Those examples show intended uses, but the announcement does not report a comparative study measuring whether the model speeds discoveries or improves scientific outcomes. The immediate change is lower-cost access for some U.S. university teams; eligibility, model approval and the limits on API use remain material conditions.
Photo by Asamoah Daniel Kwame Oware via Wikimedia Commons, dedicated under CC0 1.0. The image shows students using a microscope and is illustrative, not an OpenAI lab or program participant.
Sources
- OpenAI, Bringing GPT-Rosalind to academic research labs, October 15, 2026.
- OpenAI Help Center, Rosalind Academic Plan, eligibility, application and API terms.
- OpenAI, Introducing GPT-Rosalind for life sciences research, April 16, 2026.